Zelda Euler

2.3k total citations · 1 hit paper
23 papers, 1.2k citations indexed

About

Zelda Euler is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Zelda Euler has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 10 papers in Infectious Diseases and 9 papers in Immunology. Recurrent topics in Zelda Euler's work include HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (9 papers) and HIV/AIDS Research and Interventions (8 papers). Zelda Euler is often cited by papers focused on HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (9 papers) and HIV/AIDS Research and Interventions (8 papers). Zelda Euler collaborates with scholars based in Netherlands, United States and United Kingdom. Zelda Euler's co-authors include Hanneke Schuitemaker, Marit J. van Gils, Terri Wrin, Evelien M. Bunnik, Michael S. Seaman, Becky Schweighardt, Louise Scharf, Ten Feizi, Michel C. Nussenzweig and Hugo Mouquet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Immunology.

In The Last Decade

Zelda Euler

21 papers receiving 1.1k citations

Hit Papers

Complex-type N -glycan recognition by potent broadly neut... 2012 2026 2016 2021 2012 100 200 300 400

Peers

Zelda Euler
Krisha McKee United States
S A Tilley United States
Catherine M. Finnegan United States
L J Boots United States
Zachary Caldwell United States
Amarendra Pegu United States
John Pietzsch United States
T K Hart United States
Zelda Euler
Citations per year, relative to Zelda Euler Zelda Euler (= 1×) peers Ariel Halper-Stromberg

Countries citing papers authored by Zelda Euler

Since Specialization
Citations

This map shows the geographic impact of Zelda Euler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelda Euler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelda Euler more than expected).

Fields of papers citing papers by Zelda Euler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelda Euler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelda Euler. The network helps show where Zelda Euler may publish in the future.

Co-authorship network of co-authors of Zelda Euler

This figure shows the co-authorship network connecting the top 25 collaborators of Zelda Euler. A scholar is included among the top collaborators of Zelda Euler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelda Euler. Zelda Euler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Chan, Annemiek Verwilligen, Jerald Sadoff, et al.. (2024). Absolute quantitation of binding antibodies from clinical samples. npj Vaccines. 9(1). 8–8. 5 indexed citations
2.
Euler, Zelda, Roger D. Kouyos, Damien C. Tully, et al.. (2019). Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users. Viruses. 11(4). 384–384. 4 indexed citations
3.
Mabuka, Jenniffer M., Anne‐Sophie Dugast, Daniel Muema, et al.. (2017). Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies. Frontiers in Immunology. 8. 1104–1104. 26 indexed citations
4.
Cornelissen, Marion, Zelda Euler, Tom L.G.M. van den Kerkhof, et al.. (2016). The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype. AIDS Research and Human Retroviruses. 32(10-11). 1135–1142. 10 indexed citations
5.
McCoy, Laura E., Emilia Falkowska, Katie J. Doores, et al.. (2015). Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies. PLoS Pathogens. 11(8). e1005110–e1005110. 64 indexed citations
6.
Euler, Zelda & Galit Alter. (2014). Exploring the Potential of Monoclonal Antibody Therapeutics for HIV-1 Eradication. AIDS Research and Human Retroviruses. 31(1). 13–24. 41 indexed citations
7.
Euler, Zelda, Marit J. van Gils, Brigitte Boeser‐Nunnink, Hanneke Schuitemaker, & Daniëlle van Manen. (2013). Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals. PLoS ONE. 8(1). e54684–e54684. 16 indexed citations
8.
Kerkhof, Tom L.G.M. van den, K. Anton Feenstra, Zelda Euler, et al.. (2013). HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity. Retrovirology. 10(1). 102–102. 27 indexed citations
9.
Lynch, Rebecca M., Lillian Tran, Mark K. Louder, et al.. (2012). The Development of CD4 Binding Site Antibodies during HIV-1 Infection. Journal of Virology. 86(14). 7588–7595. 95 indexed citations
10.
Ruffin, Nicolas, Zelda Euler, Fabio Fiorino, et al.. (2012). Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011. Journal of Translational Medicine. 10(1). 5 indexed citations
11.
Euler, Zelda & Hanneke Schuitemaker. (2012). Cross-reactive broadly neutralizing antibodies: timing is everything. Frontiers in Immunology. 3. 215–215. 22 indexed citations
13.
Weger, Vincent A. de, Annelies W. Turksma, Quirinus J.M. Voorham, et al.. (2011). Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer. Clinical Cancer Research. 18(3). 882–889. 54 indexed citations
14.
Euler, Zelda, Tom L.G.M. van den Kerkhof, Marit J. van Gils, et al.. (2011). Longitudinal Analysis of Early HIV-1-Specific Neutralizing Activity in an Elite Neutralizer and in Five Patients Who Developed Cross-Reactive Neutralizing Activity. Journal of Virology. 86(4). 2045–2055. 44 indexed citations
15.
Euler, Zelda, Evelien M. Bunnik, Judith A. Burger, et al.. (2011). Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic. Journal of Virology. 85(14). 7236–7245. 42 indexed citations
16.
Bunnik, Evelien M., Zelda Euler, Matthijs R. A. Welkers, et al.. (2010). Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level. Nature Medicine. 16(9). 995–997. 89 indexed citations
17.
Euler, Zelda, Marit J. van Gils, Evelien M. Bunnik, et al.. (2010). Cross‐Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression. The Journal of Infectious Diseases. 201(7). 1045–1053. 108 indexed citations
18.
Gils, Marit J. van, Zelda Euler, Becky Schweighardt, Terri Wrin, & Hanneke Schuitemaker. (2009). Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression. AIDS. 23(18). 2405–2414. 83 indexed citations
20.
Bunnik, Evelien M., Zelda Euler, Matthijs R. A. Welkers, et al.. (2009). P04-49 LB. Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level. Retrovirology. 6(S3).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026